Lataa...

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

Dasatinib is associated with increased risk of bleeding among patients with chronic myeloid leukemia, even in the absence of thrombocytopenia, suggesting the presence of a hemostatic defect. We tested platelet aggregation in 91 patients with chronic myeloid leukemia in chronic phase either off-thera...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Quintás-Cardama, Alfonso, Han, Xin, Kantarjian, Hagop, Cortes, Jorge
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2009
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952950/
https://ncbi.nlm.nih.gov/pubmed/19414863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-180604
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!